Semaglutide Archives

Unlocking the Potential Glucagon Like Peptide 1 (GLP-1) Receptor Agonists in Type 2 Diabetes Management

by Ravina PandyaFebruary 7, 2024

Understanding GLP-1 Physiology GLP-1 is a hormone released by L cells in the intestines in response to food intake. It stimulates insulin secretion, suppresses glucagon …

Semaglutide Market Propelled by the Growing Popularity of Weight Loss Drugs

by Ravina PandyaJanuary 19, 2024

Semaglutide is an analog of the glucagon-like peptide-1 (GLP-1) hormone that is used for the treatment of obesity and type 2 diabetes. It mimics the …

The Semaglutide Market Estimated To Witness Strong Growth Due To High Diabetes Incidence And Government Support For Novel Therapies

by Ravina PandyaOctober 30, 2023

The Semaglutide market is estimated to be valued at US$ 2.17 Billion in 2022 and is expected to exhibit a CAGR of 8.71% over the …